{"id":"W4292411599","doi":"10.1016/j.esmoop.2022.100562","title":"Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study","year":2022,"lang":"en","type":"article","venue":"ESMO Open","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; PharmaMar; Servier; Astellas Pharma; Eisai; Incyte; Seagen; Gilead Sciences; Ipsen; BeiGene; Sanofi; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Atezolizumab; Internal medicine; Oncology; Adverse effect; Tolerability; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00253826,0.001226104,0.002107585,0.0003389604,0.0003353214,0.0007893972,0.0005011222,0.0007764953,0.001791266],"category_scores_gemma":[0.0009284317,0.0004740359,0.001591445,0.0004997084,0.0007195045,0.0007321381,0.0002719256,0.00236484,0.0004789987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007933159,"about_ca_system_score_gemma":0.001304225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006336023,"about_ca_topic_score_gemma":0.001074519,"domain_scores_codex":[0.9993922,0.0003147326,0.00003727659,0.00009794341,0.00006099717,0.00009691733],"domain_scores_gemma":[0.9991373,0.00012242,0.0001968905,0.00008355797,0.00006962175,0.0003902085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.70209,0.08341966,0.01485419,0.001145793,0.002438337,0.0002753717,0.000399104,0.002847607,0.04475087,0.0002014673,0.003954159,0.1436234],"study_design_scores_gemma":[0.4232766,0.5461267,0.02335324,0.00003479028,0.0007442654,0.0002848748,0.00006115885,0.001227251,0.002231672,0.00009825592,0.002535623,0.00002559575],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942929,0.002822024,0.0003685537,0.0002715989,0.00008317075,0.0009580823,0.0005186276,0.00005466563,0.0006304791],"genre_scores_gemma":[0.9926965,0.002069297,0.001106236,0.000587479,0.0002032664,0.0009393794,0.001539925,0.00002100537,0.0008368933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00253826,"threshold_uncertainty_score":0.0134238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0494886679412191,"score_gpt":0.3824033392055332,"score_spread":0.3329146712643141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}